These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15102054)

  • 1. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
    Lung FD; Chen CH; Liou CC; Chen HY
    J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding potency of peptide fragments of type 1 collagen cross-linked N-telopeptide measured by an enzyme-linked immunosorbant assay.
    Lung FD; Chen CH; Chen HY; Liou CC; Liou YM
    Protein Pept Lett; 2002 Oct; 9(5):451-7. PubMed ID: 12370034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a peptide ELISA for the detection of rituximab in serum.
    Blasco H; Lalmanach G; Godat E; Maurel MC; Canepa S; Belghazi M; Paintaud G; Degenne D; Chatelut E; Cartron G; Le Guellec C
    J Immunol Methods; 2007 Aug; 325(1-2):127-39. PubMed ID: 17651747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an assay for the quantification of type I collagen synthesis in the guinea pig.
    Quasnichka HL; Tarlton JF; Anderson-Mackenzie JM; Billingham ME; Bailey AJ; Pickford AR
    J Immunol Methods; 2005 Feb; 297(1-2):133-41. PubMed ID: 15777937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative surface plasmon resonance and enzyme-linked immunosorbent assay characterisation of a monoclonal antibody with N-acyl homoserine lactones.
    Wöllner K; Chen X; Kremmer E; Krämer PM
    Anal Chim Acta; 2010 Dec; 683(1):113-8. PubMed ID: 21094389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance.
    Ward LD; Shi PT; Simpson RJ
    Biochem Int; 1992 Mar; 26(3):559-65. PubMed ID: 1627166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of microcystins in environmental samples using surface plasmon resonance biosensor.
    Hu C; Gan N; Chen Y; Bi L; Zhang X; Song L
    Talanta; 2009 Nov; 80(1):407-10. PubMed ID: 19782244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
    Brady JD; Ju J; Robins SP
    Clin Sci (Lond); 1999 Feb; 96(2):209-15. PubMed ID: 9918902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface plasmon resonance biosensor for direct detection of antibodies against human growth hormone.
    Kausaite-Minkstimiene A; Ramanaviciene A; Ramanavicius A
    Analyst; 2009 Oct; 134(10):2051-7. PubMed ID: 19768212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous flow immunosensor for highly selective and real-time detection of sub-ppb levels of 2-hydroxybiphenyl by using surface plasmon resonance imaging.
    Gobi KV; Tanaka H; Shoyama Y; Miura N
    Biosens Bioelectron; 2004 Sep; 20(2):350-7. PubMed ID: 15308241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital.
    Gillett MJ; Vasikaran SD
    Pathology; 2006 Feb; 38(1):49-52. PubMed ID: 16484009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of binding of antibodies with recombinant house dust mite allergen (rDer p2) by surface plasmon resonance technique].
    Liu ZG; Huang HZ; Yuan P
    Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Feb; 29(2):293-6. PubMed ID: 19445188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface plasmon resonance-based trace detection of small molecules by competitive and signal enhancement immunoreaction.
    Aizawa H; Tozuka M; Kurosawa S; Kobayashi K; Reddy SM; Higuchi M
    Anal Chim Acta; 2007 May; 591(2):191-4. PubMed ID: 17481407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
    Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
    Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring bone loss using ELISA and surface plasmon resonance (SPR) technology.
    Lung FD; Chen HY; Lin HT
    Protein Pept Lett; 2003 Jun; 10(3):313-9. PubMed ID: 12871151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions of phytochrome A (Pr vs. Pfr) with monoclonal antibodies probed by a surface plasmon resonance technique.
    Natori C; Kim JI; Bhoo SH; Han YJ; Hanzawa H; Furuya M; Song PS
    Photochem Photobiol Sci; 2007 Jan; 6(1):83-9. PubMed ID: 17200742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
    Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
    Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
    Townsend S; Finlay WJ; Hearty S; O'Kennedy R
    Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology.
    Nechansky A
    J Pharm Biomed Anal; 2010 Jan; 51(1):252-4. PubMed ID: 19679421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.